Table 2 HR and P value in different age and stage groups.

From: Population-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to age

 

Hazard ratio (Stage II)

95% CI

P

Hazard ratio (Stage III)

95% CI

P

< = 50

2.014

(0.9032–4.490)

0.0871

1.168

(0.8298–1.6461)

0.3723

>50

0.741

(0.5993–0.9168)

0.0058

0.656

(0.5646–0.7642)

5.26e-08

Back to article page